We demonstrated that five LNA/DNA mixmers we designed efficiently induce exon inclusion and recover the expression of SMN protein in type I SMA patient fibroblasts (Figs 3 and 4). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.